← Back to Search

Fabric

Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting

N/A
Waitlist Available
Led By Kenneth E Schmader, MD
Research Sponsored by Precision Fabrics Group, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly for 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

The primary purpose of this research study is to evaluate if DermaTherapy® bedding will significantly reduce pressure ulcer incidence by decreasing maceration, friction, and shearing among residents of Nursing Homes.

Eligible Conditions
  • Bedsores

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly for 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly for 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Prevention and reduction in the incidence of pressure ulcers
Secondary study objectives
Reduction of bacterial contamination

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: DermaTherapy® Linen groupExperimental Treatment1 Intervention
The DermaTherapy® Linen group uses bed sheets and underpads made with DermaTherapy® fabric.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DermaTherapy® Linen and underpads.
2010
N/A
~80

Find a Location

Who is running the clinical trial?

Precision Fabrics Group, Inc.Lead Sponsor
3 Previous Clinical Trials
3,458 Total Patients Enrolled
US Department of Veterans AffairsFED
875 Previous Clinical Trials
498,346 Total Patients Enrolled
Kenneth E Schmader, MDPrincipal InvestigatorDurham VA medical Center, Duke University Medical Center
1 Previous Clinical Trials
75 Total Patients Enrolled
Jack I Twersky, MDPrincipal InvestigatorDurham VA Medical Center, Duke University Medical Center
1 Previous Clinical Trials
75 Total Patients Enrolled
~5 spots leftby Jan 2026